Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Oncology|May 1, 1995
A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folatesS Barni, P Lissoni, M Cazzaniga, et al.
The International Journal of Biological Markers|April 19, 2005
The favorable prognostic significance of surgery-induced hyperprolactinemia in node-positive breast cancer patients: ten-year disease-free survival resultsA Bignami, P Lissoni, F Brivio, et al.
Anticancer Research|May 16, 2009
Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patientsP Lissoni, F Brivio, L Fumagalli, et al.
Journal of Biological Regulators and Homeostatic Agents|March 7, 2000
Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic diseaseP Lissoni, L Vigore, R Ferranti, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|August 4, 2024
Automated segmentation in pelvic radiotherapy: A comprehensive evaluation of ATLAS-, machine learning-, and deep learning-based modelsB Bordigoni, S Trivellato, R Pellegrini, et al.
Journal of Biological Regulators and Homeostatic Agents|July 25, 1998
Physiopathology of IL-12 in human solid neoplasms: blood levels of IL-12 in early or advanced cancer patients, and their variations with surgery and immunotherapyP Lissoni, S Mengo, M Mandalà, et al.
Clinical and Translational Radiation Oncology|October 19, 2023
Contouring of emerging organs-at-risk (OARS) of the female pelvis and interobserver variability: A study by the Italian association of radiotherapy and clinical oncology (AIRO)A Augurio, G Macchia, L Caravatta, et al.
Urologia Internationalis|April 27, 2000
Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patientsV Bordin, L Giani, S Meregalli, et al.
Pageof 3